RenovaCare Inc., a stem cell therapy developer, announced on Wednesday it has established new corporate headquarters in Roseland and laboratory facilities in Berlin, Germany.
The new offices will help advance the development of its patented technologies for spraying on self-donated stem cells to regenerate skin and other organs and tissues.
“We are enthusiastic about our new corporate headquarters in New Jersey and tapping into its deep scientific and biomedical talent along with the area’s strong financial investment community,”Alan L. Rubino, CEO of RenovaCare, said.
RenovaCare also announced it has named Dr. Katrin Zeilinger as the newest member of its team. She will be working under Dr. Roger Esteban-Vives, vice president of research and product development. Previously, she served as the head of the bioreactor group at the Berlin-Brandenburg Center for Regenerative Therapies, Charité-Berlin. She will
“Our new laboratory facilities in Berlin, Germany are staffed with experts in regenerative product development and bioengineering sectors. We will also continue to work in conjunction with StemCell Systems on the next iterations of RenovaCare technology in the same place where our SkinGun™ technology was originally conceived,” Rubino said.